Improvement Effect of Metformin on Female and Male Reproduction in Endocrine Pathologies and Its Mechanisms
Metformin (MF), a first-line drug to treat type 2 diabetes mellitus (T2DM), alone and in combination with other drugs, restores the ovarian function in women with polycystic ovary syndrome (PCOS) and improves fetal development, pregnancy outcomes and offspring health in gestational diabetes mellitus...
Saved in:
Main Author: | Alexander O. Shpakov (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune-Endocrine Cross-Talk in Reproductive Biology and Pathology
by: António M. Galvão, et al.
Published: (2014) -
Exposure to Endocrine Disrupting Chemicals and Male Reproductive Health
by: Hueiwang Anna Jeng
Published: (2014) -
Changes in male reproductive health and effects of endocrine disruptors in Scandinavian countries
by: Jorma Toppari, et al. -
Changes in male reproductive health and effects of endocrine disruptors in Scandinavian countries
by: Toppari Jorma, et al.
Published: (2002) -
Pathologies of the skin and its appendages in endocrine diseases
by: Hubert Arasiewicz, et al.
Published: (2016)